Item 5.07 Submission of Matters to a Vote of Security Holders.

Decibel Therapeutics, Inc. (the "Company") held its 2022 annual meeting of stockholders on June 17, 2022. The following is a summary of the matters voted on at that meeting.

(a)

The stockholders of the Company elected one Class I director, Alison Finger, M.B.A., to serve for a three-year term expiring at the 2025 annual meeting of stockholders and until her successor has been duly elected and qualified. The results of the stockholders' vote with respect to the election of the Class I director were as follows:



Name                       For       Withheld   Broker Non-Votes
Alison Finger, M.B.A.   17,996,169    25,861       3,123,761



(b)

The stockholders of the Company ratified the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2022. The results of the stockholders' vote with respect to such ratification were as follows:



    For       Against   Abstain   Broker Non-Votes
 21,129,235    2,824    13,732           -

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses